These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8985153)

  • 21. Novel aminomethylindole derivatives as inhibitors of pp60c-Src tyrosine kinase: synthesis and biological activity.
    Işgör YG; Kiliç Z; Olgen S
    Chem Biol Drug Des; 2008 Dec; 72(6):599-604. PubMed ID: 19090928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
    Cobb BS; Parsons JT
    Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of Src SH3 ligands from phage-displayed random peptide libraries.
    Sparks AB; Quilliam LA; Thorn JM; Der CJ; Kay BK
    J Biol Chem; 1994 Sep; 269(39):23853-6. PubMed ID: 7929027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examination of the dephosphorylation reactions catalyzed by pp60c-src tyrosine kinase explores the roles of autophosphorylation and SH2 ligand binding.
    Boerner RJ; Kassel DB; Edison AM; Knight WB
    Biochemistry; 1995 Nov; 34(45):14852-60. PubMed ID: 7578095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of indole esters as inhibitors of p60(c-Src) receptor tyrosine kinase and investigation of the inhibition using receptor docking studies.
    Olgen S; Akaho E; Nebioglu D
    J Enzyme Inhib Med Chem; 2003 Dec; 18(6):485-90. PubMed ID: 15008512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro phosphorylation of the epidermal growth factor receptor autophosphorylation domain by c-src: identification of phosphorylation sites and c-src SH2 domain binding sites.
    Lombardo CR; Consler TG; Kassel DB
    Biochemistry; 1995 Dec; 34(50):16456-66. PubMed ID: 8845374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coordinate activation of c-Src by SH3- and SH2-binding sites on a novel p130Cas-related protein, Sin.
    Alexandropoulos K; Baltimore D
    Genes Dev; 1996 Jun; 10(11):1341-55. PubMed ID: 8647432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural basis for the activity of pp60(c-src) protein tyrosine kinase inhibitors.
    Prabhu NV; Siddiqui SA; McMurray JS; Pettitt BM
    Biopolymers; 2001 Sep; 59(3):167-79. PubMed ID: 11391566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phage display selection of ligand residues important for Src homology 3 domain binding specificity.
    Rickles RJ; Botfield MC; Zhou XM; Henry PA; Brugge JS; Zoller MJ
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10909-13. PubMed ID: 7479908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of c-Src tyrosine kinase activity by the Src SH2 domain.
    Liu X; Brodeur SR; Gish G; Songyang Z; Cantley LC; Laudano AP; Pawson T
    Oncogene; 1993 May; 8(5):1119-26. PubMed ID: 7683128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spleen protein tyrosine kinases TPK-IIB and CSK display different immunoreactivity and opposite specificities toward c-src-derived peptides.
    Brunati AM; Allee G; Marin O; Donella-Deana A; Cesaro L; Bougeret C; Fagard R; Benarous R; Fischer S; Pinna LA
    FEBS Lett; 1992 Nov; 313(3):291-4. PubMed ID: 1280230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A protein kinase assay system for both acidic and basic peptides.
    Lou Q; Wu J; Lam KS
    Anal Biochem; 1996 Mar; 235(1):107-9. PubMed ID: 8850556
    [No Abstract]   [Full Text] [Related]  

  • 33. High-throughput identification of substrate specificity for protein kinase by using an improved one-bead-one-compound library approach.
    Kim YG; Shin DS; Kim EM; Park HY; Lee CS; Kim JH; Lee BS; Lee YS; Kim BG
    Angew Chem Int Ed Engl; 2007; 46(28):5408-11. PubMed ID: 17554743
    [No Abstract]   [Full Text] [Related]  

  • 34. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.
    Lansing TJ; Turk BF; Kanner SB; Gilmer TM
    Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequence specificity of C-terminal Src kinase (CSK)--a comparison with Src-related kinases c-Fgr and Lyn.
    Ruzzene M; Songyang Z; Marin O; Donella-Deana A; Brunati AM; Guerra B; Agostinis P; Cantley LC; Pinna LA
    Eur J Biochem; 1997 Jun; 246(2):433-9. PubMed ID: 9208935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Why ligand cross-reactivity is high within peptide recognition domain families? A case study on human c-Src SH3 domain.
    He P; Wu W; Wang HD; Liao KL; Zhang W; Lv FL; Yang K
    J Theor Biol; 2014 Jan; 340():30-7. PubMed ID: 24021866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sam68 from an immortalised B-cell line associates with a subset of SH3 domains.
    Finan PM; Hall A; Kellie S
    FEBS Lett; 1996 Jul; 389(2):141-4. PubMed ID: 8766817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of c-Src on tyrosine 527 by another protein tyrosine kinase.
    Thomas JE; Soriano P; Brugge JS
    Science; 1991 Oct; 254(5031):568-71. PubMed ID: 1719633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural determinants for potent, selective dual site inhibition of human pp60c-src by 4-anilinoquinazolines.
    Tian G; Cory M; Smith AA; Knight WB
    Biochemistry; 2001 Jun; 40(24):7084-91. PubMed ID: 11401553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D-QSAR studies on c-Src kinase inhibitors and docking analyses of a potent dual kinase inhibitor of c-Src and c-Abl kinases.
    Thaimattam R; Daga PR; Banerjee R; Iqbal J
    Bioorg Med Chem; 2005 Aug; 13(15):4704-12. PubMed ID: 15914012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.